Earendil Labs to collaborate with Sanofi on bispecific antibodies for autoimmune diseases
Insilico Medicine announces $888m collaboration with Servier
Small chip predicts drug side effects and acute kidney injury
Awakening dormant immune cells inside tumours to attack cancer
CRISPR screen reveals genes required for brain development and a new neurodevelopmental disorder
Osaka looks to become global life sciences hub
Positive data moving breast cancer trial forward
Engineering dendritic cells boosts cancer immunotherapy
Ambros Therapeutics launches with $125m to take on complex regional pain syndrome type 1
ADEL and Sanofi sign $1.04bn licence agreement for Alzheimer’s therapy
Aukera Therapeutics emerges from stealth
FDA clears allogeneic CAR-T recurrent glioblastoma therapy for phase II trial